surmount 4 tirzepatide Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity

SURMOUNT-4 results just published in @JAMA_current 🛑Stopping #tirzepatide leads to regain of the majority of the lost weight. Is this a surprising result ⁉️ No #Obesity is a chronic disease and requires

25.53

★★★★☆4.8 (126)

In the SURMOUNT-4 trial, 82.5% of adults with obesity regained ≥25% of initial weight lost within one year of tirzepatide withdrawal; most showed reversal of cardiometabolic improvements. https://bit.ly/4rBMZgh

28.13

★★★★★4.9 (98)

Time to weight plateau with tirzepatide treatment in the SURMOUNT‐1 and SURMOUNT‐4 clinical trials - Horn - 2025 - Clinical Obesity

23.88

★★★★★5.0 (157)

Direct Link to JAMA Post Hoc Analysis of SURMOUNT-4: Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity : r/Zepbound

21.68

★★★★★4.7 (84)

Tirzepatide Demonstrates Sustained Weight Loss but Discontinuation Results in Weight Regain: SURMOUNT-4 Trial

20.53

★★★★★4.9 (203)

❗️SURMOUNT-4 Maintenance effects of Tirzepatide vs placebo ❗️#EASD2023 🔸great weight loss with percentage weight loss>25% in over half on treatment 🔹expected weight regain off treatment 🔸impressive BP reduction 🔹unusual to see the

28.30

★★★★★5.0 (176)

SURMOUNT-4研究 Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38-48. doi:10.1001/jama.2023.24945

20.40

★★★★★4.8 (132)